| Literature DB >> 3214091 |
P D Hoeprich1, N M Flynn, M M Kawachi, K K Lee, R M Lawrence, L K Heath, C P Schaffner.
Abstract
AME appeared to be as effective as AmB in the treatment of mycoses in humans. AME was much less nephrotoxic than AmB, and was better tolerated in terms of rapid onset and reversible adverse reactions. AME may be more ototoxic than AmB. AME, even as AmB and OAME, may cause neurotoxicity and leukoencephalopathy, particularly when high doses are given for long periods.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3214091 DOI： 10.1111/j.1749-6632.1988.tb40449.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691